BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9134833)

  • 1. [Long-term follow-up study of children with minimal change nephrotic syndrome].
    Takeichi S; Tazawa M; Morooka M; Minowa S; Yasaki T
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):155-60. PubMed ID: 9134833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
    Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
    Brodehl J; Krohn HP; Ehrich JH
    Klin Padiatr; 1982; 194(3):162-5. PubMed ID: 6752557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional therapy for idiopathic nephrotic syndrome in children.
    Brodehl J
    Clin Nephrol; 1991; 35 Suppl 1():S8-15. PubMed ID: 1860269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
    Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
    Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
    Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and response to treatment of minimal change nephrotic syndrome.
    Prabhakar KS; Prakash KC; Mani MK
    J Assoc Physicians India; 1993 May; 41(5):263-5. PubMed ID: 8300454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C; Melvin T; Kim Y
    Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
    Clasen W; Kindler J; Mihatsch MJ; Sieberth HG
    Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A; El-Husseini A; El-Dahshan K; Sobh M
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal change glomerular disease in Malaysian adults and use of alternate day steroid therapy.
    Wang F; Looi LM; Chua CT
    Q J Med; 1982; 51(203):312-28. PubMed ID: 7146313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.